Critical Role for Sphingosine Kinase-1 in Regulating Survival of Neuroblastoma Cells Exposed to Amyloid-β Peptide
Authors:
- Dimitri PchejetskiDimitri Pchejetski
- Leyre BrizuelaLBLeyre Brizuela
- Virginie GarciaVGVirginie Garcia
- Marie-Françoise AltiéMAMarie-Françoise Altié
- Marie-Lise MaddeleinMMMarie-Lise Maddelein
- Marie-Bernadette DelisleMDMarie-Bernadette Delisle
- Olivier CuvillierOCOlivier Cuvillier
- 1 August 2007
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 72 (2) , 341-349
Abstract
We examined the role of sphingosine kinase-1 (SphK1), a critical regulator of the ceramide/sphingosine 1-phosphate (S1P) biostat, in the regulation of death and survival of SH-SY5Y neuroblastoma cells in response to amyloid β (Aβ) peptide (25-35). Upon incubation with Aβ, SH-SY5Y cells displayed a marked down-regulation of SphK1 activity coupled with an increase in the ceramide/S1P ratio followed by cell death. This mechanism was redox-sensitive; N-acetylcysteine totally abrogated the down-regulation of SphK1 activity and strongly inhibited Aβ-induced cell death. SphK1 overexpression impaired the cytotoxicity of Aβ, whereas SphK1 silencing by RNA interference mimicked Aβ-induced cell death, thereby establishing a critical role for SphK1. We further demonstrated that SphK1 could mediate the well established cytoprotective action of insulin-like growth factor (IGF-I) against Aβ toxicity. A dominant-negative form of SphK1 or its pharmacological inhibition not only abrogated IGF-I-triggered stimulation of SphK1 but also hampered IGF-I protective effect. Similarly to IGF-I, the neuroprotective action of TGF-β1 was also dependent on SphK1 activity; activation of SphK1 as well as cell survival were impeded by a dominant-negative form of SphK1. Taken together, these results provide the first illustration of SphK1 role as a critical regulator of death and survival of Aβ-treated cells.Keywords
This publication has 50 references indexed in Scilit:
- Unequal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SH-SY5Y Neuroblastoma Cells: Role of Nicotinic ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1Leukemia, 2005
- Inflammatory mediator and β-amyloid (25–35)-induced ceramide generation and iNOS expression are inhibited by vitamin EFree Radical Biology and Medicine, 2004
- The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's diseaseEuropean Journal of Pharmacology, 2004
- Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's diseaseProceedings of the National Academy of Sciences, 2004
- Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's diseaseBiochemical Society Transactions, 2004
- Decrease of TGF-β1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's diseaseExperimental Gerontology, 2002
- A Novel Enzyme That Catalyzes the Esterification of -AcetylsphingosineJournal of Biological Chemistry, 1996
- Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphateNature, 1996
- Transforming growth factor-β protects human neurons against β-amyloid-induced injuryMolecular and Chemical Neuropathology, 1994